Higher Incidence of Chronic Infections to Drive Immunoassay Analyzers Market to USD 20.5 Billion by 2020

Higher Incidence of Chronic Infections to Drive Immunoassay Analyzers Market to USD 20.5 Billion by 2020

Immunoassay Analyzers Market – Global Immunoassay Instruments and Applications Analysis and Forecast 2016-2020, estimates the global immunoassay analyzers market to reach nearly USD 20.5 Billion in 2020, at a CAGR of 6.4% from 2016 to 2020 – iHealthcareAnalyst, Inc.

Visit the Immunoassay Analyzers Market – Global Immunoassay Instruments and Applications Analysis and Forecast 2016-2020 report https://www.ihealthcareanalyst.com/report/immunoassay-instruments-market/

The immunoassay analyzers are used in hospital and clinical laboratories to run automated biochemical tests to detect the presence and concentration of substances in the clinical samples. There are many types of tests that immunoassay analyzers can perform, including testing for cancer markers, diagnosing infectious diseases, cardiac analysis, therapeutic drug monitoring, and allergy testing. These several kinds of immunoassays are based on: chemiluminescence, enzyme immunoassay, enzyme-linked Fluorescence, immunofluorescence, multiplexed assays and radioimmunoassay. The global immunoassay analyzers market report estimates the market size (Revenue USD million – 2013 to 2020) and composition of this market and also forecasts growth trends (CAGR% – 2016 to 2020). It also covers the major companies operating in the market and provides detailed market analysis of the different immunoassay systems available in the global market.

The global immunoassay analyzers market is segmented as:

  1. Product/Analyzer/Instrument
    • Chemiluminescence (CLI) Analyzers
    • Enzyme Immunoassay Instruments
    • Enzyme Linked Fluorescent Systems
    • Immunofluorescence (IFA) Analyzers
    • Multiplexed Assay Systems
    • Radioimmunoassay Analyzers
    • Others
  1. Application
    • Autoimmune Diseases
    • Cardiology
    • Drugs of Abuse
    • Endocrinology
    • Infectious Diseases
    • Oncology
    • Therapeutic Drug Monitoring
    • Others
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories
    • bioMerieux, Inc.
    • Danaher Corporation (Beckman Coulter, Inc.)
    • DiaSorin S.p.A
    • Hoffman-La Roche, Ltd.
    • Merck Millipore
    • Ortho Clinical Diagnostics
    • Siemens Healthcare
    • Sysmex Corporation
    • Thermo Fisher Scientific

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:19:42+00:00 Categories: Press Releases|
Translate »